Search Results
Dec 11, 2025, 08:00 ET Manor House Films, John Devaney, and N3ON host Miami Art Week celebration at the iconic Scarface Mansion to celebrate art, film, and the creator economy
adapts to a rapidly changing digital landscape. He's a remarkably talented young man with incredible promise, and I truly believe he's going to the moon. I'd love to see him in an upcoming project — he would be an amazing actor."When asked about their growing production company, Devaney said, "Corinne
More news about: Manor House Films
Dec 11, 2025, 08:00 ET HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
translational innovation, and next-generation therapeutic strategies across innate and adaptive immunity.Presentation Details:Abstract ID: 242MOTitle: HCB101, a Differentiated SIRPα Fusion Protein, Demonstrates Favorable Safety and Early Antitumor Activity Across Solid
More news about: HanchorBio Inc.
Dec 11, 2025, 07:25 ET 54% of consumers say tariffs are forcing personal spending cuts, Achieve survey finds
of Achieve Company, including Achieve.com, Equal Housing Opportunity (NMLS ID #138464); Achieve Home Loans, Equal Housing Opportunity (NMLS ID #1810501); Achieve Personal Loans (NMLS ID #227977); Achieve Debt Relief (NMLS ID # 1248929); and Freedom Financial Asset Management (CRD #170229).ContactsAustin
More news about: Achieve
Dec 11, 2025, 05:02 ET iQIYI Scream Night 2025 Rayakan Keunggulan Kreatif dan Momentum Industri
multimedia:https://www.prnewswire.com/id/rilis-berita/iqiyi-scream-night-2025-rayakan-keunggulan-kreatif-dan-momentum-industri-302638976.htmlSOURCE
More news about: iQIYI Inc.
Dec 11, 2025, 04:29 ET Menurut GSMA, Indonesia Harus Mempercepat Investasi Digital yang Ditargetkan Agar Menjadi Salah Satu Negara Digital yang Terdepan di Asia Pasifik
content:https://www.prnewswire.com/id/rilis-berita/menurut-gsma-indonesia-harus-mempercepat-investasi-digital-yang-ditargetkan-agar-menjadi-salah-satu-negara-digital-yang-terdepan-di-asia-pasifik-302638947.htmlSOURCE
More news about: GSMA
Dec 11, 2025, 04:00 ET Gravity veröffentlicht weltweit das hybride Gelegenheitsspiel „Ragnarok Monster Kitchen"!
https://apps.apple.com/id/app/ragnarok-monster-kitchen/id6749607765[Ragnarok Monster Kitchen Offizieller Discord]
More news about: Gravity
Dec 11, 2025, 04:00 ET Gravity Launches Hybrid Casual Game 'Ragnarok Monster Kitchen' Worldwide!
https://apps.apple.com/id/app/ragnarok-monster-kitchen/id6749607765[Ragnarok Monster Kitchen Official Discord]
More news about: Gravity
Dec 11, 2025, 02:05 ET LEPAS L8 Exquisite Space: Suaka Emosional yang Penuh Ketenangan untuk Gaya Hidup Sehari-hari
multimedia:https://www.prnewswire.com/id/rilis-berita/lepas-l8-exquisite-space-suaka-emosional-yang-penuh-ketenangan-untuk-gaya-hidup-sehari-hari-302638854.htmlSOURCE
More news about: LEPAS
Dec 11, 2025, 02:00 ET Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
and will keep global development and commercialization rights for Staccato® alprazolam, which is currently in Phase 3 clinical trial (CinicalTrial.gov ID: NCT05077904), reinforcing the clinical maturity and commercial potential of the Staccato® OBT® platform. UCB acquired Engaged Therapeutics, Inc. for
More news about: Lee's Pharmaceutical Holdings Limited
Dec 11, 2025, 02:00 ET Lee's Pharmaceutical Holdings Limited erwirbt Staccato® One Breath Technology® Plattform und Vermögenswerte, um seine Pipeline zu erweitern und die globale Partnerschaft mit UCB durch die erworbenen Rechte voranzutreiben
weltweiten Entwicklungs- und Vermarktungsrechte für Alprazolam Staccato®, das sich derzeit in einer klinischen Studie der Phase 3 befindet (CinicalTrial.gov ID: NCT05077904), was die klinische Reife und das kommerzielle Potenzial der Staccato® OBT®-Plattform unterstreicht. UCB erwarb im Juni 2020 Engaged Therapeutics,
More news about: Lee's Pharmaceutical Holdings Limited
Dec 11, 2025, 02:00 ET Lee's Pharmaceutical Holdings Limited acquiert la plateforme et les actifs de Staccato® One Breath Technology®, renforçant ainsi l'expansion de son pipeline et faisant progresser son partenariat mondial avec UCB grâce aux droits acquis
mondiaux de développement et de commercialisation de l'alprazolam Staccato®, qui fait actuellement l'objet d'un essai clinique de phase 3 (CinicalTrial.gov ID) : NCT05077904), ce qui renforce la maturité clinique et le potentiel commercial de la plateforme Staccato® OBT®. UCB a acquis Engaged Therapeutics, Inc.
More news about: Lee's Pharmaceutical Holdings Limited
Dec 11, 2025, 02:00 ET Lee's Pharm adquiere la plataforma y los activos de Staccato® One Breath Technology®
derechos globales de desarrollo y comercialización de Staccato® alprazolam, que actualmente se encuentra en fase 3 de ensayos clínicos (CinicalTrial.gov ID: NCT05077904), lo que refuerza la madurez clínica y el potencial comercial de la plataforma Staccato® OBT®. UCB adquirió Engaged Therapeutics, Inc. para
More news about: Lee's Pharmaceutical Holdings Limited
Dec 11, 2025, 01:35 ET ISLAND HOSPITAL DINOBATKAN SEBAGAI "FLAGSHIP MEDICAL TOURISM HOSPITAL" PERTAMA DI MALAYSIA
multimedia:https://www.prnewswire.com/id/rilis-berita/island-hospital-dinobatkan-sebagai-flagship-medical-tourism-hospital-pertama-di-malaysia-302638836.htmlSOURCE
More news about: Island Hospital Sdn. Bhd
Dec 10, 2025, 23:39 ET Rosen Law Firm Encourages Balancer Investors to Inquire About Securities Class Action Investigation - BAL
https://rosenlegal.com/submit-form/?case_id=48945
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 23:37 ET INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=21452 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 23:35 ET GAUZ Investors Have Opportunity to Lead Gauzy Ltd. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=48715 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 23:34 ET FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
https://rosenlegal.com/submit-form/?case_id=45553 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 19:00 ET Lee's Pharmaceutical Holdings Limited、Staccato® One Breath Technology®プラットフォームおよび関連資産を取得、パイプラインの拡大を推進し、取得権利を通じてUCBとのグローバルパートナーシップを強化
を持つバイオ医薬品企業であるUCBとの間で既存の世界的なライセンスおよび製造供給契約に基づくAlexzaの権利と義務を取得します。この契約に基づき、UCBはStaccato®アルプラゾラムのグローバルな開発および商業化の権利を保持しており、現在第3相臨床試験（ClinicalTrial.gov ID: NCT05077904）が行われていますが、これはStaccato® OBT®プラットフォームの臨床的成熟度と商業的可能性を裏付けるものです。UCBは2020年6月にStaccato®アルプラゾラムに関してEngaged Therapeutics, Inc.を買収し、Alexzaと改訂されたライセンス契約および関連する商業供給契約を締結しました。[1]所定の開発、規制承認、販売に関するマイルストーンを達成した場合、Lee's
More news about: Lee's Pharmaceutical Holdings Limited
Dec 10, 2025, 19:00 ET 리스 파마슈티컬, 스타카토 원 브레스 테크놀로지 플랫폼 및 자산 인수... 파이프라인 확장 및 UCB와 글로벌 협력 가속화
획득이러한 이점과 더불어 회사는 뇌전증 치료 분야에서 강력한 입지를 가진 바이오 제약사 유씨비(UCB)와의 기존 전 세계 라이선스 및 제조 공급 계약에 따른 알렉자의 권리와 의무를 인수한다. 이 계약에 따라 UCB는 현재 임상 3상 시험(CinicalTrial.gov ID: NCT05077904) 중인 스타카토 알프라졸람에 대한 글로벌 개발 및 상용화 권리를 보유하고 유지하며, 이는 스타카토 OBT 플랫폼의 임상적 성숙도와 상업적 잠재력을 뒷받침한다. UCB는 2020년 6월 스타카토 알프라졸람을 위해 인게이지드 테라퓨틱스(Engaged
More news about: Lee's Pharmaceutical Holdings Limited
Dec 10, 2025, 18:00 ET PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=48085 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 17:47 ET STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit
https://rosenlegal.com/submit-form/?case_id=48412 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 17:38 ET LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=30689 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 17:32 ET OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=48876 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 16:55 ET PRMB, PRMW Investors Have Opportunity to Lead Primo Brands Corporation Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Dec 10, 2025, 16:47 ET Rosen Law Firm Encourages America's Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation - CRMT
https://rosenlegal.com/submit-form/?case_id=46025 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.